ARCHIVES

Waksals Keep ImClone Jobs, BMS Pumps $200M Into C225

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

New CREG Cell Kinetics Study Axed By DCTBSC

March 31, 1978

In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge

June 25, 1982

Cancer Centers: John Glick to step down after 21 years directing Penn’s Abramson Cancer Center.

December 2, 2005

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

NCI Develops Plan For Specialized Centers, But Funding $67.5M Program Depends On New $$

July 5, 1991

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011